CommScope Hldg Co’s Return On Capital Employed Insights

According to Benzinga Pro, during Q1, CommScope Hldg Co (NASDAQ:COMM) earned $3.40 million, a 100.31% increase from the…

According to Benzinga Pro, during Q1, CommScope Hldg Co (NASDAQ:COMM) earned $3.40 million, a 100.31% increase from the preceding quarter. CommScope Hldg Co’s sales decreased to $2.00 billion, a 13.63% change since Q4. In Q4, CommScope Hldg Co brought in $2.32 billion in sales but lost $1.11 billion in earnings.

What Is Return On Capital Employed?

Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company’s ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q1, CommScope Hldg Co posted an ROCE of -0.01%.

Keep in mind, while ROCE is a good measure of a company’s recent performance, it is not a highly reliable predictor of a company’s earnings or sales in the near future.

ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows CommScope Hldg Co is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For CommScope Hldg Co, a negative ROCE ratio of -0.01% suggests that management may not be effectively allocating their capital. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns; poor capital allocation can be a leech on the performance of a company over time.

Upcoming Earnings Estimate

CommScope Hldg Co reported Q1 earnings per share at $0.35/share, which beat analyst predictions of $0.33/share.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Recap: Fulgent Genetics Q2 Earnings

Fulgent Genetics (NASDAQ:FLGT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat estimated earnings by 6.85%, reporting an EPS of $0.78 versus an estimate of $0.73.

FLGT

Read More

Recap: Marathon Oil Q2 Earnings

Marathon Oil (NYSE:MRO) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Marathon Oil beat estimated earnings by 2.33%, reporting an EPS of $1.32 versus an estimate of $1.29.

MRO